Flemming Hald Steffensen

Flemming Hald Steffensen

Auto-generated profile, based on publicly available information

Flemming Hald Steffensen

Department of Cardiology, LilleBaelt Hospital, Vejle, Denmark (F.H.S., M.B.).

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2016 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
LKLars Valeur Köber
Lars Valeur Köber
JTJens J. Thune
Jens J. Thune
JNJens C. Nielsen
Jens C. Nielsen
JHJens Haarbo
Jens Haarbo
LVLars Videbæk
Lars Videbæk
SPSteen Pehrson
Steen Pehrson
The benefit of an implantable cardioverter–defibrillator (ICD) in patients with symptomatic systolic heart failure caused by coronary artery disease has been well documented. However, the evidence for a benefit of prophylactic ICDs in patients with systolic heart failure that is not due to coronary artery disease has been based primarily on subgroup analyses. The management of heart failure has improved since the landmark ICD trials, and many patients now receive cardiac resynchronization therapy (CRT).

23 April 1998 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
Henrik Toft SørensenHenrik Toft Sørensen
Henrik Toft Sørensen
LMLene Mellemkjær
Lene Mellemkjær
FSFlemming Hald Steffensen
Flemming Hald Steffensen
JOJørgen H. Olsen
Jørgen H. Olsen
GNGunnar Lauge Nielsen
Gunnar Lauge Nielsen
Several small studies have indicated an association between deep venous thrombosis or pulmonary embolism and a subsequent diagnosis of cancer, but the subject is controversial.

15 April 1999 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
Henrik Toft SørensenHenrik Toft Sørensen
Henrik Toft Sørensen
SSSvend Sabroe
Svend Sabroe
KRKenneth J. Rothman
Kenneth J. Rothman
MGMatthew Gillman
Matthew Gillman
FSFlemming Hald Steffensen
Flemming Hald Steffensen
TSThorkild I. A. Serensen
Thorkild I. A. Serensen
Adult height has been found to be inversely associated with mortality. Recently, it has been suggested that growth in utero is linked with adult risk of several chronic diseases. The authors examined possible associations between birth weight, birth length, and adult height in young Danish men. They conducted the study in the fifth conscription district of Denmark including all the men born after January 1, 1973 who were residents in the study area during the period August 1, 1993 to July 31, 1994. The Danish Medical Birth Register contains information on all births in Denmark since January 1, 1973. Data on height from the Conscription Register were linked to the Danish Medical Birth Register in 4, 300 conscripts examined. Nearly all Danish men have to register with the draft board around age 18 years of age where they undergo a physical examination. There was a strong positive association between birth weight and adutt height; for subjects with birth weight ≤2, 500 g, mean height was 175.7 cm, while for those with birth weight ≥4, 501 g, mean height was 184.1 cm. A positive association was also found between birth length and adult height. For subjects with birth length 56 cm. The associations between birth length and adult height persisted after adjustment for birth weight, gestational age, and other confounders, while the associations between birth weight and adult height almost disappeared when adjusting for birth length and the same confounders. Genetic and/or environmental factors operating both during the pre- and postnatal period may be responsible for the association between birth length and adult height. Am J Epidemiol 1999; 149: 726–9.

13 April 1999 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
COC Olesen
C Olesen
FSF H Steffensen
F H Steffensen
GNG L Nielsen
G L Nielsen
LBL De Jong-Van Den Berg
L De Jong-Van Den Berg
JOJ Olsen
J Olsen
Henrik Toft SørensenHenrik Toft Sørensen
Henrik Toft Sørensen

1 March 2000 in Epidemiology
Verified
Journal Article
Closed access
FSFlemming Hald Steffensen
Flemming Hald Steffensen
Henrik Toft SørensenHenrik Toft Sørensen
Henrik Toft Sørensen
MGMatthew W. Gillman
Matthew W. Gillman
KRKenneth J. Rothman
Kenneth J. Rothman
SSSvend Sabroe
Svend Sabroe
JOJørn Olsen
Jørn Olsen
Gestational factors have been hypothesized to play a role in the susceptibility to asthma and atopic dermatitis. We examined whether fetal growth was associated with asthma and atopic dermatitis separately in a population of 4,795 male conscripts born between 1973 and 1975 in Denmark. The prevalence of asthma was 4.7%. The prevalence odds ratio of asthma in conscripts with a birth weight below 2,501 g was 1.5 (95% confidence interval = 0.7–3.1) compared with conscripts with a birth weight of 3,001–3,500 g, adjusted for gestational age and potential confounders. The adjusted prevalence odds ratio among conscripts born before 34 gestational weeks was 0.8 (95% confidence interval = 0.3–2.0) compared with conscripts born at term. The prevalence of atopic dermatitis was 1.0%. The prevalence odds ratio of atopic dermatitis among those with a birth weight below 2,501 g was 3.0 (95% confidence interval = 0.8–11.9) compared with those whose birth weight was between 3,001 and 3,500 g. Men whose gestational age had been below 34 weeks had an adjusted prevalence odds ratio of 0.3 (95% confidence interval = 0.0–3.1). These findings indicate that fetal growth retardation rather than preterm delivery of male infants is the main gestational factor underlying the associations but does not explain the apparent increase over time of asthma or atopic diseases.

16 January 2000 in Headache: The Journal of Head and Face Pain
Verified
Journal Article
Closed access
PDF file
COCharlotte Olesen
Charlotte Olesen
FSFlemming Hald Steffensen
Flemming Hald Steffensen
Henrik Toft SørensenHenrik Toft Sørensen
Henrik Toft Sørensen
GNGunnar Lauge Nielsen
Gunnar Lauge Nielsen
JOJørn Olsen
Jørn Olsen